Ledger.Open graph →
SEC Form D · filed November 16, 2021

Antios Therapeutics Inc

Offering
$86.0M
Sold
$75.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MENDHAM, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Amol Jain · Menlo Park, CAExecRobert Jr. Davenport · Midland, TXDirectorGiorgi Gogokhia · San Francisco, CADirectorPatrick Higgins · Mendham, NJDirectorAnurag Bhardwaj · REDWOOD CITY, CAExec · DirectorRaymond Wong · HOUSTON, TXDirectorCraig Gordon · Bend, ORDirectorRandy S. Blount · Nashville, TNDirectorJonathan S. Campbell · Nashville, TNDirectorJason B. Betesh · New York, NYExec · DirectorIyona Rajkomar · Mendham, NJDirectorSeth B. Saideman · New York, NYDirectorWinners Circle JV LLC · Baltimore, MDExecAaron Witt · Nashville, TNDirectorJessica Saylor · Nashville, TNExecBrooke B. Klink · New York, NYExecNima Golsharifi · San Francisco, CADirectorTamra Adams · Mendham, NJExecDaniel Briscoe · Nashville, TNDirectorAbel De La Rosa · Mendham, NJDirectorBenjamin Rovinski · Mendham, NJDirectorGregory Mayes · Mendham, NJExec · DirectorDouglas Mayers · Mendham, NJExecScott Morenstein · Mendham, NJDirectorAmish Mehta · REDWOOD CITY, CADirectorCraig Gordon · Purchase, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗